サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/12/17 | 1,177 | 1,254 | 1,044 | 1,132 | +35 | +3.2% | 6,320,300 |
2021/12/16 | 1,097 | 1,097 | 1,097 | 1,097 | +150 | +15.8% | 92,100 |
2021/12/15 | 940 | 951 | 933 | 947 | -8 | -0.8% | 442,800 |
2021/12/14 | 964 | 978 | 942 | 955 | -21 | -2.2% | 491,400 |
2021/12/13 | 1,020 | 1,030 | 968 | 976 | -49 | -4.8% | 600,700 |
2021/12/10 | 1,050 | 1,054 | 1,025 | 1,025 | -29 | -2.8% | 255,100 |
2021/12/09 | 1,049 | 1,075 | 1,041 | 1,054 | +8 | +0.8% | 365,300 |
2021/12/08 | 1,000 | 1,049 | 999 | 1,046 | +60 | +6.1% | 650,300 |
2021/12/07 | 950 | 991 | 950 | 986 | +35 | +3.7% | 604,600 |
2021/12/06 | 990 | 992 | 940 | 951 | -64 | -6.3% | 807,600 |
2021/12/03 | 987 | 1,015 | 982 | 1,015 | +34 | +3.5% | 418,100 |
2021/12/02 | 1,006 | 1,017 | 980 | 981 | -37 | -3.6% | 508,900 |
2021/12/01 | 1,033 | 1,035 | 997 | 1,018 | -15 | -1.5% | 515,400 |
2021/11/30 | 1,029 | 1,066 | 1,016 | 1,033 | +20 | +2% | 508,500 |
2021/11/29 | 1,051 | 1,073 | 1,011 | 1,013 | -70 | -6.5% | 982,500 |
2021/11/26 | 1,140 | 1,144 | 1,071 | 1,083 | -71 | -6.2% | 759,100 |
2021/11/25 | 1,164 | 1,180 | 1,137 | 1,154 | -4 | -0.3% | 361,900 |
2021/11/24 | 1,208 | 1,208 | 1,157 | 1,158 | -63 | -5.2% | 497,600 |
2021/11/22 | 1,212 | 1,227 | 1,189 | 1,221 | -10 | -0.8% | 280,800 |
2021/11/19 | 1,302 | 1,302 | 1,231 | 1,231 | -73 | -5.6% | 382,500 |
2021/11/18 | 1,291 | 1,318 | 1,261 | 1,304 | +24 | +1.9% | 644,200 |
2021/11/17 | 1,307 | 1,338 | 1,238 | 1,280 | +59 | +4.8% | 1,409,500 |
2021/11/16 | 1,203 | 1,221 | 1,182 | 1,221 | +23 | +1.9% | 227,200 |
2021/11/15 | 1,177 | 1,203 | 1,165 | 1,198 | +13 | +1.1% | 257,000 |
2021/11/12 | 1,142 | 1,191 | 1,141 | 1,185 | +29 | +2.5% | 244,500 |
2021/11/11 | 1,174 | 1,179 | 1,152 | 1,156 | -33 | -2.8% | 230,100 |
2021/11/10 | 1,177 | 1,205 | 1,168 | 1,189 | +15 | +1.3% | 208,000 |
2021/11/09 | 1,179 | 1,191 | 1,166 | 1,174 | -7 | -0.6% | 150,400 |
2021/11/08 | 1,224 | 1,224 | 1,175 | 1,181 | -44 | -3.6% | 257,900 |
2021/11/05 | 1,205 | 1,228 | 1,196 | 1,225 | +27 | +2.3% | 202,000 |
2021/11/04 | 1,245 | 1,246 | 1,193 | 1,198 | -29 | -2.4% | 260,600 |
2021/11/02 | 1,222 | 1,244 | 1,221 | 1,227 | +29 | +2.4% | 207,100 |
2021/11/01 | 1,224 | 1,224 | 1,183 | 1,198 | -3 | -0.2% | 173,500 |
2021/10/29 | 1,241 | 1,245 | 1,200 | 1,201 | -32 | -2.6% | 190,900 |
2021/10/28 | 1,251 | 1,256 | 1,233 | 1,233 | -28 | -2.2% | 150,300 |
2021/10/27 | 1,228 | 1,264 | 1,228 | 1,261 | +37 | +3% | 341,400 |
2021/10/26 | 1,177 | 1,228 | 1,177 | 1,224 | +50 | +4.3% | 240,900 |
2021/10/25 | 1,191 | 1,191 | 1,160 | 1,174 | -32 | -2.7% | 296,800 |
2021/10/22 | 1,198 | 1,224 | 1,188 | 1,206 | -14 | -1.1% | 257,400 |
2021/10/21 | 1,279 | 1,279 | 1,205 | 1,220 | -63 | -4.9% | 345,500 |
2021/10/20 | 1,268 | 1,286 | 1,251 | 1,283 | +25 | +2% | 267,300 |
2021/10/19 | 1,242 | 1,265 | 1,237 | 1,258 | +16 | +1.3% | 172,900 |
2021/10/18 | 1,232 | 1,251 | 1,216 | 1,242 | +2 | +0.2% | 259,400 |
2021/10/15 | 1,190 | 1,240 | 1,175 | 1,240 | +79 | +6.8% | 474,800 |
2021/10/14 | 1,133 | 1,169 | 1,133 | 1,161 | +33 | +2.9% | 256,000 |
2021/10/13 | 1,124 | 1,140 | 1,119 | 1,128 | -2 | -0.2% | 165,400 |
2021/10/12 | 1,142 | 1,153 | 1,124 | 1,130 | -24 | -2.1% | 202,400 |
2021/10/11 | 1,149 | 1,160 | 1,118 | 1,154 | +6 | +0.5% | 295,300 |
2021/10/08 | 1,116 | 1,149 | 1,110 | 1,148 | +38 | +3.4% | 298,700 |
2021/10/07 | 1,092 | 1,124 | 1,087 | 1,110 | +14 | +1.3% | 296,900 |
901~
950
件表示中 / 2536件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 253,000円 | - | - | 0.00% | - | 117.18倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 152,500円 | +5.0% | +1.5% | 0.00% | 13.05倍 | 3.67倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
科研薬 | 388,200円 | -6.4% | -71.8% | 4.89% | 43.23倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 304,000円 | +7.9% | -3.3% | 2.63% | 8.46倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム